Rimonabant, cannabinoid CB1 receptor antagonist/inverse agonist (ab144582)

Publishing research using ab144582? Please let us know so that we can cite the reference in this datasheet.

ab144582 has been referenced in 2 publications.

  • Nallathambi R  et al. Anti-Inflammatory Activity in Colon Models Is Derived from ?9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts. Cannabis Cannabinoid Res 2:167-182 (2017). PubMed: 29082314
  • Li MH  et al. Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain. J Neurosci 37:626-636 (2017). Rat . PubMed: 28100744

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up